Skip to main content
TipRanks
Go Ultimate75% OFF

Clal Insurance (CLIS) AI Stock Analysis

2 Followers
IL:CLIS

Clal Insurance

(TASE:CLIS)

Select Model
Rating:64Neutral
Price Target:ILA 26,814.00â–²(7.00% Upside)
Action:downgraded
Date:11/21/26

The overall score of 64 reflects a mixed investment profile led by a highly attractive valuation and surging bottom-line profitability. However, these fundamental strengths are heavily offset by notable risks, primarily a massive recent increase in debt leverage, top-line revenue volatility, and broad bearish technical trends across all major moving averages.

Positive Factors
Strong profitabilityImproved profitability and a roughly 22.3% return on equity indicate strong earnings power from the existing capital base. If maintained, these returns can support internal reinvestment, strengthen resilience, and create a durable foundation for shareholder value over the next several quarters.
Negative Factors
Higher leverageThe sharp increase in debt-to-equity materially raises sensitivity to adverse investment or underwriting outcomes. Greater leverage can constrain capital allocation, increase financing pressure, and reduce the company’s ability to absorb prolonged volatility compared with its lower-debt history.

Clal Insurance (CLIS) vs. iShares MSCI Israel ETF (EIS)

-10%0%10%20%30%40%50%60%70%IL:CLIS+34.31%EIS+1.01%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
ILS 20.26B
Dividend Yield
1.98%
Average Volume (3M)
270.32K
Price to Earnings (P/E)
8.4
Beta (1Y)
1.71
Revenue Growth
-30.50%
EPS Growth
67.45%
Country
Israel
Employees
3,610
Sector
Financial
Sector Strength
68
Industry
Insurance - Diversified

Clal Insurance Business Overview & Revenue Model

Company Description

Clal Insurance Enterprises Holdings Ltd., an Israeli firm, delivers a comprehensive array of insurance solutions. Its business operations are structured into three main divisions: Long-Term Savings, Non-Life Insurance, and Health Insurance. The Long-...

How the Company Makes Money

Clal Insurance primarily makes money through a combination of (1) underwriting income on insurance policies, (2) investment income on assets it manages and invests, and (3) fees and charges related to long-term savings and asset-management-type activ...

Clal Insurance Financial Statement Overview

Summary

Clal Insurance presents robust profitability with surging net income and a 22.3% ROE, successfully recovering to positive free cash flow. However, the score is constrained by significant revenue volatility and a dramatic spike in total debt, creating leverage risks that require careful monitoring.

Income Statement

72Positive

Balance Sheet

62Positive

Cash Flow

70Positive
Financial statement breakdown
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue16.62B15.13B26.83B21.45B7.31B25.06B
Gross Profit15.15B15.13B25.93B20.43B6.11B24.00B
EBITDA4.97B4.77B2.33B1.46B729.00M2.14B
Net Income2.39B2.28B718.00M220.00M121.00M1.08B
Balance Sheet
Total Assets195.87B188.36B170.10B163.62B144.62B145.51B
Cash, Cash Equivalents and Short-Term Investments4.27B4.06B20.15B8.64B13.90B26.53B
Total Debt19.58B17.31B15.54B777.00M5.13B4.86B
Total Liabilities184.24B177.44B160.57B154.97B136.56B137.73B
Stockholders Equity11.54B10.83B9.45B8.58B8.00B7.72B
Cash Flow
Free Cash Flow1.72B2.18B1.32B-4.64B-2.80B6.87B
Operating Cash Flow1.89B2.24B1.38B-4.31B-2.59B7.09B
Investing Cash Flow-2.23B-2.35B-1.08B-2.24B-365.96M-162.00M
Financing Cash Flow2.56B1.47B-79.00M1.44B785.33M16.00M

Clal Insurance Technical Analysis

Technical Analysis SentimentNegative
Last Price25060.00

Price Trends

50DMA27776.40Negative
100DMA25766.00Negative
200DMA25286.12Negative

Market Momentum

MACD-646.45Positive
RSI37.34Neutral
STOCH22.00Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IL:CLIS, the sentiment is Negative. The current price of 25060.00 is below the 20-day moving average (MA) of 26629.50, below the 50-day MA of 27776.40, and below the 200-day MA of 25286.12, indicating a bearish trend. The MACD of -646.45 indicates Positive momentum. The RSI at 37.34 is Neutral, neither overbought nor oversold. The STOCH value of 22.00 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IL:CLIS.

Clal Insurance Peers Comparison

Overall Rating

UnderperformOutperform
Sector (68)

Financial Indicators

IL:CLIS against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
IL:MMHDIL:MMHD77OutperformILS 29.25B11.68―3.42%18.14%49.80%
IL:PHOEIL:PHOE76OutperformILS 41.94B12.64―3.33%10.88%24.40%
IL:HARLIL:HARL71OutperformILS 36.06B11.0027.03%3.97%14.74%70.44%
Sector *68Neutral$18.00B11.429.92%3.81%9.73%1.22%
IL:AYALIL:AYAL66NeutralILS 4.15B8.75―3.21%――
IL:CLISIL:CLIS64NeutralILS 20.26B8.43―1.98%-30.50%67.45%
IL:MGDLIL:MGDL57NeutralILS 18.49B9.75――-9.35%35.96%

* Financial Sector Average

Performance Comparison

0%50%100%IL:CLISIL:HARLIL:MGDLIL:PHOEIL:MMHDIL:AYALDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
IL:CLIS and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
IL:CLISClal Insurance Enterprises Holdings 25060.005363.6127.23%
IL:HARLHarel Insurance Investments & Financial Services 17550.005802.3449.39%
IL:MGDLMigdal Insurance & Financial Holdings Ltd.1745.00429.0032.60%
IL:PHOEPhoenix Holdings Ltd.16610.003490.6726.61%
IL:MMHDMenora Mivtachim Holdings Ltd.46810.0011105.2731.10%
IL:AYALAyalon Holdings Ltd.14610.006119.2872.07%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Nov 20, 2026